{
  "report_rows": [
    {
      "kpi": "Core EPS",
      "prediction": "BEAT",
      "answer": "pred ~$3.32 vs. cons ~$3.18",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Business Insurance underlying combined ratio",
      "prediction": "IN-LINE",
      "answer": "pred ~89.4 vs. cons ~89.5",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Consolidated net investment income (pre-tax)",
      "prediction": "BEAT",
      "answer": "pred ~$755M vs. cons ~$725M",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Business Insurance ex-comp renewal written price change (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "guide ~6% vs. cons ~5.5% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Employee Benefits full-year core margin",
      "prediction": "LOWER",
      "answer": "guide ~7.0-7.5% vs. cons ~8.0% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Full-year net investment income growth",
      "prediction": "BETTER",
      "answer": "guide ~+8-10% vs. cons ~+6% (FY2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "Capital return / buyback pace",
      "prediction": "UNCHANGED",
      "answer": "guide ~$450M buyback vs. cons ~$450M (Q2/quarterly)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -1.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Even with a modest headline EPS beat driven by NII/alternatives, the print lands against the toughest comp of the year (Q2'25 $3.41 core EPS, 9.2% EB margin, $163M favorable PYD, benign CATs) into a stock near highs at ~1.9x book with 20% ROE \u2014 expectations are elevated (recall the ~3.7% drop after the Q1 beat). The debate items (softening commercial pricing, EB/disability and workers'-comp margin normalization, peak-season convective CAT risk, and lumpy PYD that won't repeat) drive implicit out-period cuts, so favorable-development-flattered EPS gets discounted and forward estimates drift lower, extending the initial negative reaction rather than reversing it.",
  "day5_confidence": "LOW"
}